Category: COPD Treatment’

Make Your Voice Heard – CMS Reducing Respiratory Therapy Reimbursement in 2017

Respiratory therapy works for ALL respiratory diseases. The research, science and years of studies have confirmed this statement of fact. However, in a period where official diagnosis and cases of Asthma, Allergies, and Chronic Obstructive Pulmonary Disease (COPD) are RISING, the Centers for Medicare and Medicaid Services (CMS) recently announced a reduction in the amounts…

Read more »

COPD Patients and Caregiver Focus Group at Pulmonary Horizons NYC Conference

As of Saturday July 16th, only 44 spots remain. This event is FREE for COPD Patients and Caregivers in the NYC area. SIGN UP TODAY! PulmonaryHorizons® 3rd Annual COPD Conference – August 12-14, 2016 PATIENT AND CAREGIVER FOCUS GROUP HILTON MEADOWLANDS East Rutherford, NJ FRIDAY AUGUST 12, 2016 – 10:00 AM TO 2:00 PM The Most…

Read more »

Volunteers Needed for Pulmonary Horizons Conference in NYC Aug 12 – 14

PulmonaryHorizons® 3rd Annual COPD Conference – August 12-14, 2016 Hilton Meadowlands and MetLife Stadium East Rutherford, NJ The Most Comprehensive – Integrated Conference – Involving All Stakeholders including the Patient with COPD to Improve Health Outcomes & Reduce Costs Volunteer Opportunities for Respiratory Therapists, Registered Nurses, Allied Health and Health Administration Professionals and Students – Receive…

Read more »

BEVESPI AEROSPHERE™ Approved by the US FDA for Patients With COPD

AstraZeneca today announced that the US Food and Drug Administration has approved BEVESPI AEROSPHERE (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.